The Spanish Agency for Medicines and Health Products (AEMPS) has introduced an accelerated evaluation process (fast-track) to enhance Spain’s appeal for research on innovative medicines. This process will reduce the timelines for studies meeting the following criteria: Interested…
This month, we want to share the acknowledgment that APICES has received in the recent publication of SPASSET Study: Healthcare Resource Utilization and Associated Costs among Patient with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain,…
The Clinical Trials Information System (CTIS) is the online system for the regulatory submission, authorization, and supervision of clinical trials in the European Union and the European Economic Area. CTIS is the single entry point for clinical trials in…
APICES attended the most important annual Biotechnology congress, BIO International Convention, which took place between June 3 and June 6 in the city of San Diego (CA – USA). The BIO International Convention is the largest and most…
This month, we want to share the acknowledgment that APICES has received in the recent publication of HEMOLIFE Study: Humanistic burden of haemophilia Awithout inhibitors: A cross-sectional analysis of the HEMOLIFE study, published in Haemophilia in which APICES has…
This month, we want to share the acknowledgment that APICES has received in the recent publication of RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain, published in Seminars…
This month, we want to share the acknowledgment that APICES has received in the recent publication of an international clinical trial, titled “Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase…
This month, we want to share the acknowledgment that APICES has received in the recent publication titled “Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study”, published…
Spanish CRO APICES boosts its expansion and growth plans with the integration of the French CRO Kappa Santé. With this operation, the Spanish company will have offices in Paris (France), consolidating its growth and fostering collaboration with other research…
This month, we want to share the acknowledgment that APICES has received in the recent publication titled “A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the Geminis study”
